Revolutionizing Medical and Wellness Delivery

Business is at the forefront of a major transformation in inhalation technology, creating innovative, water-soluble solutions designed for enhanced wellness and medical delivery. With its unique, non-heating inhalation devices, it ensures safe, effective, and precise delivery of active ingredients like cannabinoids, nicotine, and pharmaceuticals. Business goal is to create a safer alternative for consumers seeking wellness and therapeutic benefits while drastically reducing the risks associated with traditional methods like smoking and vaping.

This capital raise aims to secure $10 million to scale production, achieve regulatory milestones, and accelerate market entry into key verticals. With strategic partnerships, a revolutionary product offering, and a compelling market opportunity, it is poised to become a leader in the wellness and medical device markets.

Key Highlights:
Proprietary Technology: Patented, 100% water-soluble, non-heating technology delivers precise doses of active ingredients without the need for combustion or heat, preserving the integrity of the compounds.
Strategic Partnerships: Partnerships with leading institutions like Rose Hulman Ventures for product development, McKinney RSA for regulatory compliance, and Mursix for U.S.-based manufacturing provide product with a robust foundation for growth.
Diverse Market Opportunities: Addresses several high-growth markets, including smoking cessation, cannabinoid delivery, and pharmaceutical drug delivery, with a strong focus on Asia and emerging markets.
Sustainability and Wellness: Devices are designed to reduce environmental impact and provide a cleaner, healthier experience for users, aligning with global wellness trends.